editorial complementary and alternative medicine for the...

3
Editorial Complementary and Alternative Medicine for the Treatment of Fibromyalgia Jost Langhorst, 1 Winfried Häuser, 2,3 Romy Lauche, 1 Serge Perrot, 4 Cayetano Alegre, 5 and Piercarlo C. Sarzi Puttini 6 1 Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, 45276 Essen, Germany 2 Department of Internal Medicine 1, Klinikum Saarbr¨ ucken, 66119 Saarbr¨ ucken, Germany 3 Department of Psychosomatic Medicine and Psychotherapy, Technische Universit¨ at M¨ unchen, 81865 M¨ unchen, Germany 4 Service de M´ edecine Interne et ´ erapeutique, Centre de la Douleur, Hˆ otel Dieu, Universit´ e Paris Descartes, INSERM U 987, Paris, France 5 Department of Rheumatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain 6 Rheumatology Unit, L Sacco University Hospital, Milan, Italy Correspondence should be addressed to Jost Langhorst; [email protected] Received 17 November 2013; Accepted 17 November 2013; Published 9 January 2014 Copyright © 2014 Jost Langhorst et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. e fibromyalgia syndrome (FMS) is a chronic condition characterized by chronic widespread pain, fatigue, cognitive disturbances, sleep disorders, and somatic and psychological distress [1, 2]. Between 2.9 and 3.8% of the general population in Europe and the US are affected [35], with 9 times as many women as men in clinical settings [2]. Many patients with fibromyalgia use complementary and alternative therapies to cope with their disease. A recent con- sumers report indicated that 67.0% of German FMS patients used heat application or thermal baths, 35.2% different CAM medications such as homeopathy, dietary supplements, and vitamins, 34.6% some kind of diet, 28.5% tool-based physical therapies such as acupuncture, and 18.4% meditative exercises such as yoga or tai chi [6]. In summary, almost every FMS patient had used at least one CAM therapy for the management of FMS. In an Internet sample of US American FMS patients, the frequencies were slightly higher [7]. CAM use in FMS patients is associated with younger age, female gender, and higher overall disease burden [8, 9]. Contrary to the frequent use, only limited research has been conducted on complementary and alternative therapies so far. Data on efficacy and safety are however necessary to judge their value within the treatment regimen. Without reliable information, such therapies that might benefit FMS patients will also not be included in standard care; therapies with a negative benefit-risk ratio on the other hand might be applied despite doubts about their effects. is special issue aimed to facilitate publication of research of complementary and alternative therapies for the fibromyalgia syndrome. e papers published in this special issue were carefully selected to display a great variety of different research topics. In the following, a short overview of included papers will be provided. M.-A. Fitzcharles et al. took a closer look at classification and clinical diagnosis of the fibromyalgia syndrome. ree evidence-based interdisciplinary guidelines from Canada, Germany, and Israel were compared in terms of definition and diagnostic procedures, and consistent results have been found for all three guidelines. e results of this review further implied the importance of evidence-based guidelines for health care providers. J. N. Ablin et al. summarized the recommendations of those guidelines with a special emphasis on CAM therapies. While all guidelines supported patient- tailored approaches, recommendations differed, especially regarding CAM. Discrepancies were also present regarding the levels of evidence and the strengths of recommendation. Contrary to Germany and Israel, where some CAM therapies were recommended, no CAM treatment was recommended Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2014, Article ID 408436, 2 pages http://dx.doi.org/10.1155/2014/408436

Upload: others

Post on 03-Oct-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Editorial Complementary and Alternative Medicine for the ...downloads.hindawi.com/journals/ecam/2014/408436.pdfpational therapies. e Ayurvedic group also received indi-vidual treatment

EditorialComplementary and Alternative Medicinefor the Treatment of Fibromyalgia

Jost Langhorst,1 Winfried Häuser,2,3 Romy Lauche,1 Serge Perrot,4

Cayetano Alegre,5 and Piercarlo C. Sarzi Puttini6

1 Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine,University of Duisburg-Essen, 45276 Essen, Germany

2Department of Internal Medicine 1, Klinikum Saarbrucken, 66119 Saarbrucken, Germany3Department of Psychosomatic Medicine and Psychotherapy, Technische Universitat Munchen, 81865 Munchen, Germany4 Service de Medecine Interne et Therapeutique, Centre de la Douleur, Hotel Dieu, Universite Paris Descartes,INSERM U 987, Paris, France

5 Department of Rheumatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain6Rheumatology Unit, L Sacco University Hospital, Milan, Italy

Correspondence should be addressed to Jost Langhorst; [email protected]

Received 17 November 2013; Accepted 17 November 2013; Published 9 January 2014

Copyright © 2014 Jost Langhorst et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The fibromyalgia syndrome (FMS) is a chronic conditioncharacterized by chronic widespread pain, fatigue, cognitivedisturbances, sleep disorders, and somatic and psychologicaldistress [1, 2]. Between 2.9 and 3.8% of the general populationin Europe and the US are affected [3–5], with 9 times as manywomen as men in clinical settings [2].

Many patients with fibromyalgia use complementary andalternative therapies to cope with their disease. A recent con-sumers report indicated that 67.0% of German FMS patientsused heat application or thermal baths, 35.2% different CAMmedications such as homeopathy, dietary supplements, andvitamins, 34.6% some kind of diet, 28.5% tool-based physicaltherapies such as acupuncture, and 18.4%meditative exercisessuch as yoga or tai chi [6]. In summary, almost everyFMS patient had used at least one CAM therapy for themanagement of FMS. In an Internet sample of US AmericanFMS patients, the frequencies were slightly higher [7]. CAMuse in FMS patients is associated with younger age, femalegender, and higher overall disease burden [8, 9].

Contrary to the frequent use, only limited research hasbeen conducted on complementary and alternative therapiesso far. Data on efficacy and safety are however necessaryto judge their value within the treatment regimen. Withoutreliable information, such therapies that might benefit FMS

patients will also not be included in standard care; therapieswith a negative benefit-risk ratio on the other hand might beapplied despite doubts about their effects.

This special issue aimed to facilitate publication ofresearch of complementary and alternative therapies for thefibromyalgia syndrome. The papers published in this specialissue were carefully selected to display a great variety ofdifferent research topics. In the following, a short overviewof included papers will be provided.

M.-A. Fitzcharles et al. took a closer look at classificationand clinical diagnosis of the fibromyalgia syndrome. Threeevidence-based interdisciplinary guidelines from Canada,Germany, and Israel were compared in terms of definitionand diagnostic procedures, and consistent results have beenfound for all three guidelines. The results of this reviewfurther implied the importance of evidence-based guidelinesfor health care providers. J. N. Ablin et al. summarized therecommendations of those guidelines with a special emphasison CAM therapies. While all guidelines supported patient-tailored approaches, recommendations differed, especiallyregarding CAM. Discrepancies were also present regardingthe levels of evidence and the strengths of recommendation.Contrary to Germany and Israel, where some CAM therapieswere recommended, no CAM treatment was recommended

Hindawi Publishing CorporationEvidence-Based Complementary and Alternative MedicineVolume 2014, Article ID 408436, 2 pageshttp://dx.doi.org/10.1155/2014/408436

Page 2: Editorial Complementary and Alternative Medicine for the ...downloads.hindawi.com/journals/ecam/2014/408436.pdfpational therapies. e Ayurvedic group also received indi-vidual treatment

2 Evidence-Based Complementary and Alternative Medicine

according to the Canadian guidelines.This supports the needfor high-quality research.

Three papers reported on clinical trials. In the so-calledKAFA-trial, C. S. Kessler et al. investigated the feasibilityand efficacy of an additive complex Ayurvedic treatment in32 FMS patients, using a nonrandomized controlled studydesign. All patients received conventional care during aninpatient hospital admission with elements of physiotherapy,hydrotherapy, exercise, and cognitive behavioral and occu-pational therapies. The Ayurvedic group also received indi-vidual treatment regimen including massages, diets, yoga,and self-help strategies. At the end of two weeks, differentparameters including quality of life, pain, and sleep qualitywere assessed. A prospective observational trial by K. Kraftet al. with 70 patients tested the effects of vibration massageusing a deep oscillation device. Patients were treated twiceweekly for five weeks and followed up for two months.Outcomes included safety and tolerability, symptom severity,and quality of life. Finally, J. Sawynok et al. reported theresults of an extension trial that investigated 20 FMS patientswho had been included in a trial on the effects of qigong forsix months. Outcomes included quantitative measures suchas pain intensity, disability and quality of life, and qualitativecomments of participants.

Another fourmanuscripts reported the results of reviews;one of them was a narrative review and three were sys-tematic reviews, partially with meta-analyses. J. N. Ablin etal. provided a qualitative-narrative review and a historicalperspective on the use of spa treatment for fibromyalgia. Theauthors not only included clinical trials, but also publicationsregarding the history, the implementation of spa therapy,and related practices in different cultures and provided thereaders with a comprehensive overview. Another review byS. S. Nascimento et al. systematically reviewed the efficacyand safety of medicinal plants or related natural productsfor fibromyalgia. Eight randomized controlled trials wereincluded in this analysis; possible benefits and harms wereinvestigated. R. Lauche et al. aimed to summarize the efficacyand safety of qigong trials. Seven randomized controlledtrials with 395 were included and the authors analyzedwhether quality of life and other key symptoms were alteredby qigong interventions. An established tool to formulaterecommendation for clinical practice was also applied. And J.A. Glombiewski et al. conducted a systematic review on EMGandEEG-Biofeedback for FMS. Seven randomized controlledtrials were included based on 321 patients. Together thesereviews provide up to date information about the state ofscientific evidence for the respective topics.

The authors are confident that this special issue will pro-vide readers with an insightful cross-section of current FMSresearch topics and facilitate further high-quality research inthe CAM field for the sake of FMS patients.

Jost LanghorstWinfried Hauser

Romy LaucheSerge Perrot

Cayetano AlegrePiercarlo C. Sarzi Puttini

References

[1] W. Hauser, S. Hayo, W. Biewer et al., “Diagnosis of fibromyalgiasyndrome—a comparison of association of the medical sci-entific societies in Germany, survey, and American college ofrheumatology criteria,”The Clinical Journal of Pain, vol. 26, no.6, pp. 505–511, 2010.

[2] F. Wolfe, D. J. Clauw, M.-A. Fitzcharles et al., “The Americancollege of rheumatology preliminary diagnostic criteria forfibromyalgia and measurement of symptom severity,” ArthritisCare & Research, vol. 62, no. 5, pp. 600–610, 2010.

[3] J. C. Branco, B. Bannwarth, I. Failde et al., “Prevalence offibromyalgia: a survey in five European countries,” Seminars inArthritis and Rheumatism, vol. 39, no. 6, pp. 448–453, 2010.

[4] F. Wolfe, E. Brahler, A. Hinz, and W. Hauser, “Fibromyalgiaprevalence, somatic symptom reporting, and the dimension-ality of polysymptomatic distress: results from a survey of thegeneral population,” Arthritis Care & Research, vol. 65, no. 5,pp. 777–785, 2013.

[5] R. C. Lawrence, D. T. Felson, C. G. Helmick et al., “Estimatesof the prevalence of arthritis and other rheumatic conditions inthe United States. Part II,” Arthritis & Rheumatism, vol. 58, no.1, pp. 26–35, 2008.

[6] W. Hauser, E. Jung, B. Erbsloh-Moller et al., “Germanfibromyalgia consumer reports. Benefits and harms offibromyalgia syndrome therapies,” Der Schmerz, vol. 26, no. 2,pp. 150–159, 2012 (German).

[7] R.M. Bennett, J. Jones, D. C. Turk, I. J. Russell, and L.Matallana,“An internet survey of 2,596 people with fibromyalgia,” BMCMusculoskeletal Disorders, vol. 8, article 27, 2007.

[8] B. K. Lind, W. E. Lafferty, P. T. Tyree, P. K. Diehr, and D. E.Grembowski, “Use of complementary and alternative medicineproviders by fibromyalgia patients under insurance coverage,”Arthritis & Rheumatism, vol. 57, no. 1, pp. 71–76, 2007.

[9] P. M. Nicassio, C. Schuman, J. Kim, A. Cordova, and M. H.Weisman, “Psychosocial factors associated with complemen-tary treatment use in fibromyalgia,” The Journal of Rheumatol-ogy, vol. 24, no. 10, pp. 2008–2013, 1997.

Page 3: Editorial Complementary and Alternative Medicine for the ...downloads.hindawi.com/journals/ecam/2014/408436.pdfpational therapies. e Ayurvedic group also received indi-vidual treatment

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com